Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001567619-22-013866

Options or other derivatives

  • Chief Executive Officer acquired 161,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
BLATT LAWRENCE Chief Executive Officer 2022-07-07 Grant or award · Stock Option (Right to Buy) +161,700 161,700 D
Loading xslF345X03/doc1.xml…